Andrew Murphy - EVP Research at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Research
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Murphy since 12/7/2024

Holdings reported by Andrew Murphy for Regeneron Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50K $28.1M $562.27 Oct 30, 2025 Direct
Common Stock 4.37K $2.46M $562.27 Oct 29, 2025 By 401(k) Plan
Non-Qualified Stock Option (right to buy) 0 Oct 29, 2025 Direct Common Stock

Transactions reported by Andrew Murphy for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.